Certara acquired Applied BioMath (ABM) for $36.6 million, a transaction completed in December 2023, structured as cash with contingent earn-out.
Applied BioMath (ABM) operates in Software / Services, is based in United States. Applied BioMath (ABM) is an industry leader in model-informed drug discovery and development, using quantitative systems pharmacology (QSP) modeling to help accelerate and de-risk therapeutic research and development. Certara completed the acquisition for total estimated consideration of approximately $36.6 million, including contingent consideration against eligible-revenue thresholds (earn-out potential up to roughly $17.55 million). The deal strengthened Certara's mechanistic/QSP modeling capability across discovery and development.
Strengthen Certara's model-informed drug discovery and development capability through QSP modeling.
Industry leader in model-informed drug discovery and development.
Advisory firms were not disclosed for this transaction.